Timothy G. Dixon

President & Chief Executive Officer at Therapeutic Solutions International, Inc.

Timothy G. Dixon

Timothy G. Dixon

President & Chief Executive Officer at Therapeutic Solutions International, Inc.

Overview
Career Highlights

MolecuVax, Inc.
MxThree Dimensional Media Ic
OmniBiome, Inc.

RelSci Relationships

23

Number of Boards

4

Birthday

1959

Age

59

Relationships
RelSci Relationships are individuals Timothy G. Dixon likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Vice President, Chief Financial Officer & Secretary at Therapeutic Solutions International, Inc.

Relationship likelihood: Strong

Co-Founder at Batu Biologics, Inc.

Relationship likelihood: Strong

Chief Scientific Officer & Director at Capo Therapeutics, Inc.

Relationship likelihood: Strong

President & Chief Scientific Officer at Regen BioPharma, Inc.

Relationship likelihood: Strong

Director at Capo Therapeutics, Inc.

Relationship likelihood: Strong

Director of Neuro-Oncology, Pacific Brain Tumor Center at Providence Saint John's Health Center

Relationship likelihood: Strong

Chairman & Research Director at Vaxine Pty Ltd.

Relationship likelihood: Strong

Director at Capo Therapeutics, Inc.

Relationship likelihood: Strong

Chief Executive Officer at OmniBiome, Inc.

Relationship likelihood: Strong

Chief Medical Officer at Therapeutic Solutions International, Inc.

Relationship likelihood: Strong

Paths to Timothy G. Dixon
Potential Connections via
Relationship Science
You
Timothy G. Dixon
President & Chief Executive Officer at Therapeutic Solutions International, Inc.
Career History
Chairman & President
2015 - Current

MolecuVax, Inc. manufactures biopharmaceutical products. It offers MVAX-001, a cancer stem cell targeted immunotherapy that activates the immune system to seek and destroy cancer stem cells based on their expression of a protein named Brother of the Regulator of Imprinted Sites (BORIS). The company is headquartered in Oceanside, CA.

President
2004 - Current
President & Chief Executive Officer
Current

Therapeutic Solutions International, Inc. engages in the development of immune-modulatory agents to target certain cancers, improve maternal and fetal health, fight periodontal disease, and for daily health. It also produces nutraceuticals. The company was founded on August 6, 2007 and is headquartered in Oceanside, CA.

Boards & Committees
Chairman & President
2015 - Current

MolecuVax, Inc. manufactures biopharmaceutical products. It offers MVAX-001, a cancer stem cell targeted immunotherapy that activates the immune system to seek and destroy cancer stem cells based on their expression of a protein named Brother of the Regulator of Imprinted Sites (BORIS). The company is headquartered in Oceanside, CA.

Chairman
Current

Therapeutic Solutions International, Inc. engages in the development of immune-modulatory agents to target certain cancers, improve maternal and fetal health, fight periodontal disease, and for daily health. It also produces nutraceuticals. The company was founded on August 6, 2007 and is headquartered in Oceanside, CA.

Chairman & President
Current

OmniBiome, Inc. manufactures diagnostic kits. It focuses on developing Dx/Rx products and services for pre-pregnancy-associated and pregnancy-associated conditions or diseases where there is a substantive putative link with microbiome dysbiosis, as well as on restoring eubiosis. The company is headquartered in Oceanside, CA.

Public Holdings
Restricted data only for RelSci Professional users.